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Prepregnancy Weight, Gestational Weight Gain,
and Risk of Growth Affected Neonates
Tiffany A. Moore Simas, M.D., M.P.H., M.Ed.,1,2,3 Molly E. Waring, Ph.D.,4
Xun Liao, M.S.,1 Anne Garrison, M.D.,1,3 Gina M.T. Sullivan, M.D.,1
Allison E. Howard, B.S.,3 and Janet R. Hardy, Ph.D., M.Sc., M.P.H.1,2,5
Abstract
Background: In 2009, the Institute of Medicine published revised gestational weight gain (GWG) guidelines with
changes notable for altered body mass index (BMI) categorization as per World Health Organization criteria and
a stated range of recommended gain (11–20 pounds) for obese women. The goal of this study was to evaluate
associations between maternal BMI-specific GWG adherence in the context of these new guidelines and risk of
small for gestational age (SGA) and large for gestational age (LGA) neonates.
Methods: Subjects were a retrospective cohort of 11,203 live birth singletons delivered at 22–44 weeks at a
Massachusetts tertiary care center between April 2006 and March 2010. Primary exposure was GWG adherence
(inadequate, appropriate, or excessive) based on BMI-specific recommendations. SGA and LGA were defined as
< 10th and ‡ 90th percentiles of U.S. population growth curves, respectively. The association between GWG
adherence and SGA and LGA was examined in polytomous logistic regression models that estimated adjusted
odds ratios (AOR) stratified by prepregnancy weight status, controlling for potential confounders.
Results: Before pregnancy, 3.8% of women were underweight, 50.9% were normal weight, 24.6% were overweight,
and 20.6% were obese. Seventeen percent had inadequate GWG, and 57.2% had excessive GWG. Neonates were
9.6% SGA and 8.7% LGA. Inadequate GWG was associated with increased odds of SGA (AOR 2.51, 95% confidence
interval [CI] 1.31-4.78 for underweight and AOR 1.78, 95% CI 1.42-2.24 for normal weight women) and decreased
odds of LGA (AOR 0.5, 95% CI 0.47-0.73 for normal weight and AOR 0.56, 95% CI 0.34-0.90 for obese women).
Excessive GWG was associated with decreased odds of SGA (AOR 0.59, 95% CI 0.47-0.73 for normal weight and
AOR 0.64, 95% CI 0.47-0.89 for overweight women) and increased odds of LGA (AOR 1.76, 95% CI 1.38-2.24 for
normal weight, AOR 2.99, 95% CI 1.92-4.65 for overweight, and AOR 1.55, 95% CI 1.10-2.19 for obese women).
Conclusions: Efforts to optimize GWG are essential to reducing the proportion of SGA and LGA neonates,
regardless of prepregnancy BMI.
Introduction
Both small for gestational age (SGA) and large forgestational age (LGA) neonates are at considerable
immediate and long-term health risk. SGA neonates are at risk
for low Apgar scores, meconium aspiration, seizures, respi-
ratory complications, extended hospital stays, and long-term
sequelae, including metabolic syndrome and neurologic def-
icits.1,2 LGA neonates are at risk for cardiac anomalies, neural
tube defects, shoulder dystocia, cesarean delivery, intrauter-
ine fetal demise, neonatal intensive care unit (NICU) admis-
sions, and long-term obesity.2–5
Both prepregnancy body mass index (BMI) and gestational
weight gain (GWG) outside of recommended ranges are as-
sociated with SGA and LGA neonates. Overweight and obese
women are at increased and decreased risks for LGA and SGA
neonates, respectively.6 Regardless of prepregnancy weight
status, women who gain excessively during pregnancy are
more likely to have macrosomic infants.1–4 For normal weight
women, GWG below and above 1990 Institute of Medicine
(IOM) recommendations is associated with increased risk of
SGA and LGA neonates, respectively.7 However, considering
that 50% of pregnancies are unintended,8 for the vast majority
of women, GWG is the only weight parameter that is
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modifiable once prenatal care and associated counseling are
initiated.
In May 2009, the IOM published new recommendations
with regard to weight gain in pregnancy.9 The revised
guidelines are notable for two changes: (1) underweight,
normal weight, overweight, and obese BMI categories were
changed from the Metropolitan Life Insurance Table to World
Health Organization (WHO) cutoff points,9 and (2) obese
women were provided with a range of recommended gain
(11–20 pounds)9 compared to the prior recommendation of
‘‘at least 15 pounds’’ with an unbounded upper limit.10 Pre-
vious studies investigating associations of GWG with risk of
SGA and LGA neonates have done so in the context of 1990
IOM GWG guidelines; only the recent publication by Mar-
gerison Zilko et al.11 puts this important issue in the context of
the updated guidelines. The goal of this study was to estimate
the association between adherence to the revised 2009 IOM
prepregnancy BMI-specific GWG recommendations and the
occurrence of SGA or LGA neonates.
Materials and Methods
The University of Massachusetts Medical School’s clinical
partner, UMass Memorial Health Care’s (UMMHC) auto-
mated electronic Labor & Delivery (L&D EMR) export data-
base provided data for this retrospective cohort study. The
initial cohort consisted of > 16,000 women who delivered
singleton, live birth, nonanomalous neonates between April 1,
2006, and March 31, 2010 (Fig. 1). Neonates with congenital
anomalies as designated within the complications section of
the delivery record were excluded. Women without recorded
maternal prepregnancy weight, height, or documented GWG
were excluded. Women with missing or unknown demo-
graphics of interest (marital status, smoking status, maternal
age, parity, and race) were excluded. Women delivering at
unknown gestational age, at < 22 weeks or > 44 weeks, or
who delivered a neonate with unknown gender or with un-
known birth weight were also excluded. Finally, for women
with more than one pregnancy during the study period, one
pregnancy was randomly selected for inclusion in analyses.
Our final sample included 11,203 women and their neonates
(Fig. 1). The export database is surveyed periodically to
evaluate internal consistency by direct comparison with pa-
tient charts. Variables missing information or data outliers
were verified or corrected by chart review where possible. The
UMMS Institutional Review Board approved this study.
Prepregnancy weight status was assessed with BMI (kilo-
gram/meter2) calculated from prepregnancy weight and
height. Height in the L&D EMR was either obtained from the
prenatal record or self-reported at time of delivery. Pre-
pregnancy weight was recorded in the L&D EMR. L&D
nurses were instructed to record prepregnancy weight ac-
cording to a prioritized sequence as available: (1) self-reported
prepregnancy weight as recorded in the woman’s prenatal
record, (2) weight self-reported by the women upon admis-
sion for delivery, or (3) measured weight at first prenatal visit
as recorded in her prenatal record. Women’s prepregnancy
weight status was categorized according to 2009 IOM BMI
categories and thus is consistent with WHO categories as
follows: underweight (BMI < 18.5 kg/m2), normal weight
(18.5 kg/m2 £BMI < 25 kg/m2), overweight (25 kg/m2 £
BMI < 30 kg/m2) and obese (30 kg/m2 £BMI).9
Similar to prepregnancy weight, GWG was ascertained in
L&D EMR through one of two sources per availability: (1) self-
report at time of delivery admission or (2) documented weight
at last prenatal visit subtracted from prepregnancy weight in
prenatal records. GWG was categorized as inadequate, ap-
propriate, or excessive based on the IOM’s 2009 prepregnancy
BMI-specific GWG guidelines. Appropriateness of women’s
GWG was categorized using recommended GWG corre-
sponding to individual gestational age at delivery, thus
allowing for inclusion of preterm deliveries in addition to full-
term deliveries. To account for gestational age at delivery,
minimum and maximum recommended gains at each week of
gestational age were determined using IOM recommendations
of gain by the end of the first trimester (week 13) and trajectory
of gain throughout the second and third trimesters, assuming
the following ranges of gain achieved by the 40th week: 28–40
pounds for women who were underweight before pregnancy,
25–35 pounds for women of normal weight, 15–25 pounds for
overweight women, and 11–20 pounds for obese women.9
Neonates were considered to be SGA and LGA, respectively,
if birth weight was < 10th12 and ‡ 90th13 percentile of 1999–
2000 U.S. national reference data14 for singletons, accounting
for gestational age and gender.11 Gestational age at delivery
was based on best dates for estimated date of confinement as
per clinician evaluation and as recorded in L&D EMR.
Other characteristics abstracted from the L&D EMR and
considered as covariates were (1) maternal age (£ 19 years,
20–24 years, 25–39 years, 30–34 years, ‡ 35 years), (2) marital
status (married vs. unmarried, including single, divorced,
widowed, and separated), (3) ever smoker, which included
smoking before or any time during pregnancy, (4) parity
(nulliparous, primiparous, multiparous), (5) race/ethnicity
representing either self-reported or attributed race/ethnicity
(white, Hispanic, black, Asian, other race/ethnicity), (6) hy-
pertension diagnosis (prepregnancy or pregnancy-associated
hypertension diagnosis vs. absence of any hypertensive dis-
ease diagnosis), and (7) diabetes status (pregestational or
gestational diabetes mellitus [GDM] diagnosis vs. absence of
any diabetes diagnosis).
Statistical analyses
Demographic summary statistics are presented as either
mean– standard deviation (SD) for continuous variables or as
frequency measures for categorical variables. We initially in-
cluded women of any prepregnancy weight status in our
analyses and tested one-way interactions between covariates
using chi-square tests. The interaction between prepregnancy
weight status and adherence to GWG recommendations was
statistically significant. Therefore, we stratified our analyses
by prepregnancy weight status in order to make our results
more easily interpreted in the context of providing useful and
effective prenatal counseling.
We estimated odds ratios (ORs) and 95% confidence in-
tervals (CIs) for SGA and LGA in relation to adherence to
GWG recommendations (GWG within recommended ranges
compared to inadequate or excessive GWG), stratified by
prepregnancy weight status, using polytomous logistic re-
gression models. In polytomous logistic regression, the out-
come takes one of three or more categories, and models are
simultaneously fit using maximum likelihood to estimate ORs
for each group compared to a common reference group.15 We
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controlled for confounding using multivariate adjustment.
Covariates were considered for inclusion in the regression
models based on previous research examining GWG and
SGA/LGA,1,2,4,6,7,11,16,17 availability in the dataset, and sig-
nificance on bivariate comparisons. We initially included
in multivariate-adjusted models those covariates that were
significantly related to appropriateness of neonatal size for
gestational age category (SGA, appropriate for gestational age
[AGA], LGA) at p < 0.10 within strata of prepregnancy BMI.
Adjusted models revealed significant correlation of age with
parity or marital status on SGA, AGA, and LGA categories;
thus, age was not included in the final adjusted models.
We also performed sensitivity analyses through exami-
nation of several other models. For women < 20 years of age
at delivery, we calculated age-specific and gender-specific
BMI percentiles and defined BMI categories according to the
Singleton gestations
N = 16,201
University of Massachusetts Medical School
UMass Memorial Health Care
L&D EMR 
Export Relational Database
April 1, 2006 – March 31, 2010
Total Births = 17,217
(Total Deliveries = 16,700)
Excluded:
- Multiple gestations (n=1,016)
(478 twin sets, 20 triplet sets)
Excluded (criteria not exclusive):
- Non-live births (n=144)
- Congenital anomalies (n=84)
- Missing BMI (n=1,510)
- Missing GWG (n=2,639)
- Missing neonatal birth weight (n=205)
- Missing/unknown neonatal sex (n=20)
- Missing/unknown marital status (n=157)
- Missing/unknown smoking status (n=355)
- Missing maternal age (n=21)
- Missing parity (n=241)
- Missing/unknown race (n=471)
- GA < 22 or GA > 44 weeks (n=108)
Singleton live-birth gestations with weight 
parameters and demographics 
born 22-44 wks GA
N = 12,535
(12,535 neonates born to 11,203 mothers)
Singleton live-birth gestations with weight 
parameters and demographics 
born 22-44 wks GA
N = 11,203
(11,203 neonates born to 11,203 mothers)
(1073 SGA and 970 LGA neonates)
Random selection of one birth per mother in time 
period, thus excluded:
- One neonate born to mothers with 2 deliveries
(n=1,258)
- Two neonates born to mothers with 3 deliveries
(n=62)
FIG. 1. Study flow diagram. BMI,
body mass index; GA, gestational age;
GWG, gestational weight gain; L&D
EMR, labor and delivery electronic
medical record; LGA, large for gesta-
tional age; SGA, small for gestational
age.
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Centers for Disease Control and Prevention (CDC) defini-
tions for children: underweight (< 5th percentile), healthy
weight ( ‡ 5th and < 85th percentile), overweight ( ‡ 85th and
< 95th percentile), and obese ( ‡ 95th percentile).18 For these
analyses, at risk of overweight was considered overweight,
and overweight was considered obese with regard to con-
sideration of recommended GWG ranges. We additionally
examined models in which adolescents were excluded. As
the definitions of SGA and LGA are percentiles based on
population growth curves, and as infant birth weights have
changed over time, models using different U.S. national
reference data,19 controlling for gender, were considered.
Models in which mothers with diabetes or hypertension
were excluded from analyses were evaluated because the
relationship between these conditions and GWG is complex
and may be on the causal pathway; for example, women
with GDM may have lower GWG as a result of interventions
for their diabetes. Additionally, this dataset does not ade-
quately allow for distinction between pregestational and
gestational diagnoses regarding these disease processes. Fi-
nally, preterm deliveries were excluded in one set of models,
as reference cutoff points for SGA and LGA are less reliably
measured by fetal growth reference population curves be-
cause preterm births are biased by a significant portion of
preterm neonates being growth restricted. Analyses were
performed using SAS (version 9.2, SAS Institute Inc., Cary,
NC) statistical analysis software.
Results
Before pregnancy, 3.8% of women were underweight,
50.9% were normal weight, 24.6% were overweight, and
20.6% were obese. Nearly 75% of women gained outside of
the ranges recommended by the IOM (17.0% gained inade-
quately and 57.2% gained excessively). Women were pre-
dominantly white (63.5%), married (60.1%), multiparous
(58.6%), and nonsmokers (87.5%). Women were, on average,
aged 29.0 ( – 6.1) years. The most common comorbidities were
pregestational diabetes or GDM (6.2%) and pregestational or
pregnancy-related hypertensive disease (8%). Women were
delivered at a mean gestational age of 38.9 ( – 2.3) weeks, and
their neonates had mean birth weights of 3310.5 (– 620.0) g.
Approximately one tenth of neonates were SGA (9.6%,
n = 1073), and 8.7% were LGA (n = 970).
Table 1 displays demographics specific to combined BMI
and GWG adherence categories. Within each BMI category,
when progressing from inadequate to appropriate to exces-
sive gain, infant birth weight increased (Table 1). In each BMI
category, frequency of hypertensive disease diagnoses was
highest among women who gained excessively, and fre-
quency of preterm delivery was highest among women who
gained inadequately (Table 1).
Within BMI categories, when progressing from inadequate
to appropriate to excessive gain, frequency of SGA decreased
and frequency of LGA increased, respectively (Fig. 2). Re-
gardless of prepregnancy weight status, frequency of SGA
was lower with higher GWG; additionally, frequency of LGA
was higher among women of higher prepregnancy BMI who
experienced greater weight gain. Underweight women with
inadequate GWG had the highest frequency of SGA neonates.
Obese women who gained excessively had the highest fre-
quency of LGA neonates (Fig. 2).
Inadequate GWG was associated with increased adjusted
odds of SGA among underweight and normal weight women
(Table 2). Excessive GWG was associated with decreased
adjusted odds of SGA among normal weight and overweight
women, with trends for decreased odds in underweight and
obese women. Inadequate GWG was associated with de-
creased adjusted odds of LGA among normal weight and
obese women, with trends for decreased odds in overweight
women. Excessive GWG was associated with increased ad-
justed odds of LGA among normal weight, overweight, and
obese women, with trends for increased odds in underweight
women. It should be noted that confidence intervals are likely
wide in the underweight group because of relatively small
numbers of women in this BMI category. The results of the
various sensitivity analyses were very similar to those of the
main analyses (data not shown).
Discussion
Inadequate GWG was associated with increased odds of
SGA neonates, and excessive gain was associated with in-
creased odds of LGA neonates. Conversely, inadequate gain
was associated with decreased odds of LGA neonates, and
excessive gain was associated with decreased odds SGA neo-
nates. Using 1990 IOM guidelines, previous published studies
have reported associations between maternal prepregnancy
weight,20 maternal BMI,1,21 and GWG1,17,20 with fetal growth.
A recent review of 35 studies found strong evidence supporting
an association between excessive GWG and LGA and between
inadequate GWG and SGA.22 Our findings contribute to the
limited information available on this topic specific to the new
2009 IOM GWG guidelines and thus describe the contempo-
rary burden of growth-affected neonates born to women
gaining outside of currently recommended GWG ranges.
Margerison Zilko et al.11 is the only other group to date to have
published study findings based on the 2009 revised IOM
guidelines for GWG and neonatal outcomes of SGA or LGA. In
the current study, we found similar significant associations
between adherence to GWG recommendations and SGA and
LGA neonates, independent of maternal demographic and
pregnancy characteristics. Margerison Zilko et al.11 evaluated
the odds of SGA and LGA by prepregnancy BMI and GWG
adherence in separate adjusted models. Noting an interaction
between BMI and GWG adherence, however, we presented our
results stratified by maternal prepregnancy weight status, thus
highlighting the increased risk of SGA and LGA in a manner
directly relevant to provider counseling about GWG.
Two studies20,21 have reported increasing trends in LGA,
and a third study reported decreased birth weight (mean 52 g)
among all singleton term neonates in the U.S. between 1990
and 2005.16 This last study additionally reported that LGA
rates had decreased to 8.9%, consistent with our findings
(8.7%), and reported stable SGA rates of approximately
10.2%.16 In our study, approximately one tenth (9.6%) of ne-
onates were SGA.
It should be noted that our cohort spans the change be-
tween the 1990 and 2009 guidelines. As the American College
of Obstetricians and Gynecologists (ACOG) had not yet
clearly endorsed the 2009 guidelines, counseling practices
likely did not change in the transition period, and most wo-
men had already delivered or were pregnant when the IOM
published its updated guidelines in 2009. Thus, the term
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‘‘adherence’’ in this context most accurately describes these
study conditions. In a previous study of this patient popula-
tion, we found that counseling about GWG was limited even
before guideline changes.23 Although women in this study
were likely not counseled about GWG using the 2009 guide-
lines, this study provides an estimate of the contemporary
burden of SGA and LGA neonates associated with GWG
outside the ranges newly recommended by the IOM.
With an expected normal distribution of birth weights,
there will always be neonates who fall at the extremes, some
of whom will be constitutionally healthy, whereas others will
be pathologically affected. As clearly shown in Figure 2, some
groups of women are at significantly higher risk than ex-
pected for population burden of having an SGA or LGA
neonate. Specifically, underweight women who gain inade-
quately (29.1%) and obese women who gain excessively
(15.2%) are at significantly higher risk of delivering SGA and
LGA neonates, respectively, than the expected 10%.
The strengths of our study include a cohort study design
with a large sample of women derived from a clinical care
database. This database availed us to examine comorbidities,
thus allowing adjustment for underlying medical conditions,
such as diabetes and hypertensive disease. Our study sample
was drawn from the central Massachusetts region and
Table 2. Small and Large for Gestational Age Neonates in Relation to Prepregnancy Weight Status
and Adherence to Gestational Weight Gain Recommendations
Small for gestational age neonates Large for gestational age neonates
Prepregnancy weight
status n
Adherence to GWG
recommendations Crude Adjusted Crude Adjusted
Underweighta 427 Inadequate 2.25 (1.22-4.15) 2.51 (1.31-4.78) 0.90 (0.16-5.04) 0.92 (0.16-5.50)
Excessive 0.69 (0.36-1.32) 0.60 (0.30-1.20) 2.29 (0.70-7.47) 2.99 (0.86-10.47)
Normal weight* 5707 Inadequate 1.77 (1.42-2.20) 1.78 (1.42-2.24) 0.58 (0.39-0.87) 0.56 (0.47-0.73)
Excessive 0.67 (0.54-0.82) 0.59 (0.47-0.73) 1.73 (1.36-2.20) 1.76 (1.38-2.24)
Overweight* 2756 Inadequate 0.96 (0.6-1.53) 0.99 (0.61-1.59) 0.61 (0.26-1.43) 0.60 (0.25-1.42)
Excessive 0.71 (0.52-0.97) 0.64 (0.47-0.89) 2.79 (1.81-4.30) 2.99 (1.92-4.65)
Obese* 2313 Inadequate 0.94 (0.60-1.49) 1.01 (0.64-1.61) 0.58 (0.36-0.93) 0.56 (0.34-0.90)
Excessive 0.82 (0.56-1.20) 0.77 (0.52-1.14) 1.41 (1.01-1.98) 1.55 (1.10-2.19)
Odds ratios (95% confidence intervals.
aAdjusted analyses included the following covariates: marital status, parity, smoking, and diabetes.
*Adjusted analyses included following covariates: marital status, race, parity, smoking, diabetes, and hypertension.
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FIG. 2. Distribution of small, appropriate, and large for gestational age neonates in relation to adherence to gestational
weight gain recommendations and prepregnancy weight status. Light gray bars represent small for gestational age (SGA),
medium gray bars represent appropriate for gestational age (AGA), and darker gray bars represent large for gestational age
(LGA) neonates. Prepregnancy weight is categorized as underweight (BMI < 18.5 kg/m2), normal weight (18.5 kg/m2 £
BMI < 25 kg/m2), overweight (25 kg/m2 £BMI < 30 kg/m2), and obese (30 kg/m2 £BMI). Gestational weight gain adherence
based on BMI-specific recommendations per Institute of Medicine 2009 guidelines. Dashed lines indicate expected population
burden of SGA and LGA neonates at the 10th and 90th percentiles, respectively.
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included a patient population that is consistent with the 2008
Census Bureau’s report of U.S. racial and ethnic composition.24
Our study sample delivery dates ranged from 2006 to 2010 and
were representative of the nation’s epidemic of obesity, with
one fifth of gravidas being obese.25,26 These characteristics of
our sample potentially enhance the generalizability of our re-
sults to populations beyond those of central Massachusetts.
The use of a large clinical database facilitates examination
of birth outcomes but has inherent limitations. Evaluation of
covariates is limited by the absence of socioeconomic factors,
such as education and poverty level. Further, the manner in
which data were collected can cause unclear discernment
between preexisting vs. gestational conditions (such as dia-
betes and hypertensive diseases) and, thus, has the potential
to differentially affect results. For example, long-standing
type 1 diabetes may be associated with vascular disease and
SGA neonates,27 whereas newly diagnosed GDM is more
likely associated with LGA neonates.28 A similar limitation
was noted by Donahue et al.16 when evaluating trends in birth
weights in the United States. The association between these
comorbidities and SGA or LGA is likely complex and poten-
tially on the causal pathway; for example, weight gain is likely
affected by clinical diabetes interventions. However, we per-
formed sensitivity analyses excluding women with these co-
morbidities, and results were similar (data not shown). An
additional limitation is that weight was not measured directly
and was instead obtained from data entered into the L&D
EMR by clinical nursing staff when women were in labor. The
source of these values was either weight recalled at first pre-
natal visit or at delivery admission or weight measured at the
first prenatal visit. Although a recommended order of prior-
itized data entry exists, we cannot confirm adherence to the
recommended order. Recalled vs. measured weight has been
shown by Brown et al.29 to produce different results regarding
effect of weight gain on newborn size.
Additionally, studies have found that underweight women
tend to overestimate30 and overweight women tend to un-
derestimate31 their prepregnancy weight, and women in this
age group generally underestimate their weight and overes-
timate their heights,32 potentially causing inaccurate classifi-
cation of prepregnancy weight status and, thus, misclassified
recommended GWG range. However, self-reported and
clinically measured prepregnancy weights have been found
to be highly correlated (r= 0.99)33 and result in the same
classification of prepregnancy weight status for 85% of
women.30 The proportion of women in our study population
who were underweight before pregnancy was small in size
compared to other populations,26 and, thus, evaluation of this
group was limited. Finally, we evaluated adherence by GWG
at time of delivery as opposed to gain over specific trimesters
or other parameters. Both total gain and rate of gain do not
account for the fact that gain at specific pregnancy time points
may be more influential on maternal and fetal outcomes, a
concept that bears further consideration based on the current
available literature.29,34–42
Conclusions
BMI-specific GWG recommendations have been revised
recently by the IOM, with the goal of optimizing maternal and
neonatal immediate and long-term health outcomes. We
found inadequate GWG to be significantly associated with
increased odds of SGA for underweight and normal weight
women. We also found excessive GWG to be significantly
associated with increased odds of LGA for normal weight,
overweight, and obese women. Thus, our findings support
the updated guidelines with regard to the goal of optimizing
birth of appropriate for gestational age neonatal weights. As
weight gain during pregnancy is a modifiable factor associ-
ated with increased risk of SGA and LGA neonates, further
counseling by providers is needed to help women attain
guideline adherent weight gain during pregnancy. Further
research and public health efforts should be focused on how
to assist women in meeting these recommendations.
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